Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 8
1973 3
1974 11
1975 24
1976 26
1977 37
1978 99
1979 114
1980 168
1981 252
1982 400
1983 580
1984 745
1985 1007
1986 986
1987 893
1988 971
1989 1006
1990 953
1991 1005
1992 959
1993 942
1994 864
1995 763
1996 826
1997 780
1998 669
1999 623
2000 629
2001 538
2002 558
2003 519
2004 499
2005 505
2006 479
2007 445
2008 413
2009 387
2010 404
2011 402
2012 380
2013 366
2014 368
2015 355
2016 312
2017 281
2018 266
2019 293
2020 270
2021 220
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

23,770 results
Results by year
Filters applied: . Clear all
Page 1
Nifedipine.
Radomski L, Brody MJ. Radomski L, et al. J Iowa Med Soc. 1983 Jul;73(7):278-80. J Iowa Med Soc. 1983. PMID: 6350496 Review. No abstract available.
Pharmacokinetics and metabolism of nifedipine.
Raemsch KD, Sommer J. Raemsch KD, et al. Hypertension. 1983 Jul-Aug;5(4 Pt 2):II18-24. doi: 10.1161/01.hyp.5.4_pt_2.ii18. Hypertension. 1983. PMID: 6862586
Nifedipine is almost completely absorbed from the gastrointestinal tract as shown by plasma levels after sublingual, oral, and rectal administration. ...After oral administration of 10 mg, the mean plasma concentration of nifedipine reaches maximum values of 160 +/-
Nifedipine is almost completely absorbed from the gastrointestinal tract as shown by plasma levels after sublingual, oral, and rectal
Nifedipine.
[No authors listed] [No authors listed] Aust Nurses J. 1983 Apr;12(9):35. Aust Nurses J. 1983. PMID: 6553490 No abstract available.
Nifedipine interactions in hypertensive patients.
Salvetti A, Magagna A, Abdel-Haq B, Lenzi M, Giovannetti R. Salvetti A, et al. Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:963-8. doi: 10.1007/BF02018301. Cardiovasc Drugs Ther. 1990. PMID: 2076408 Review.
Nifedipine interactions in hypertensive patients have been evaluated, taking into account both the possibility that the inhibition of prostaglandin (PG) synthesis induced by non-steroidal antiinflammatory drugs (NSAIDs) can reduce the antihypertensive effect of nifedipi
Nifedipine interactions in hypertensive patients have been evaluated, taking into account both the possibility that the inhibition of
[Amlodipine].
Pedersen OL, Schroeder P. Pedersen OL, et al. Ugeskr Laeger. 1991 Jul 8;153(28):2021-3. Ugeskr Laeger. 1991. PMID: 1830707 Review. Danish. No abstract available.
Nifedipine and its indications in obstetrics and gynecology.
Childress CH, Katz VL. Childress CH, et al. Obstet Gynecol. 1994 Apr;83(4):616-24. doi: 10.1097/00006250-199404000-00024. Obstet Gynecol. 1994. PMID: 8134077 Review.
For acute control of hypertension, 10 mg of sublingual nifedipine may be used. Nifedipine is as effective as beta-mimetics in decreasing uterine activity. ...Nifedipine has potential and theoretical indications for dysmenorrhea and bladder irritability....
For acute control of hypertension, 10 mg of sublingual nifedipine may be used. Nifedipine is as effective as beta-mimetics in …
Use of nifedipine in the hypertensive diseases of pregnancy.
Levin AC, Doering PL, Hatton RC. Levin AC, et al. Ann Pharmacother. 1994 Dec;28(12):1371-8. doi: 10.1177/106002809402801208. Ann Pharmacother. 1994. PMID: 7696729 Review.
MAIN OUTCOME MEASURES: The primary outcome indicators included the safety and antihypertensive efficacy of nifedipine in pregnancy; the effects of nifedipine on maternal/fetal hemodynamics; and the effect, if any, of nifedipine on perinatal outcome. ...Howeve …
MAIN OUTCOME MEASURES: The primary outcome indicators included the safety and antihypertensive efficacy of nifedipine in pregnancy; t …
Nifedipine gastrointestinal therapeutic system: an overview of its antiatherosclerotic effects.
Ueng KC, Lin MC, Chan KC, Lin CS. Ueng KC, et al. Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):769-80. doi: 10.1517/17425255.3.5.769. Expert Opin Drug Metab Toxicol. 2007. PMID: 17916061 Review.
Experimental studies in animal models provided early evidence of the antiatherosclerotic effects of nifedipine in reducing and reversing plaque formation and improving endothelial function. Over the past decade, clinical trials, including 'Intervention as a Goal in Hyperte …
Experimental studies in animal models provided early evidence of the antiatherosclerotic effects of nifedipine in reducing and revers …
Sublingual nifedipine: the continuing controversy.
Oliver S. Oliver S. Aust Crit Care. 1994 Jun;7(2):12-4. doi: 10.1016/s1036-7314(94)70197-1. Aust Crit Care. 1994. PMID: 8061479 Review.
Sublingual, as opposed to oral, administration of Nifedipine (Adalat) has gained wide popularity as the method of choice when the most rapid onset of anti-hypertensive action is required. ...The lack of a standardised technique for the administration of sublingual Nifed
Sublingual, as opposed to oral, administration of Nifedipine (Adalat) has gained wide popularity as the method of choice when the mos …
Nifedipine trials.
Messerli FH. Messerli FH. Circulation. 1997 Mar 18;95(6):1671-2. Circulation. 1997. PMID: 9118550 No abstract available.
23,770 results
You have reached the last available page of results. Please see the User Guide for more information.